Arteris, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)
(unaudited)
| As of | |||||||
| December 31, 2021 | December 31, 2020 | ||||||
| ASSETS | |||||||
| Currents assets: | |||||||
| Cash | $ | 85,825 | $ | 11,744 | |||
| Accounts receivable, net | 13,873 | 14,350 | |||||
| Prepaid expenses and other current assets | 6,949 | 2,858 | |||||
| Total current assets | 106,647 | 28,952 | |||||
| Property and equipment, net | 2,438 | 2,365 | |||||
| Operating lease right-of-used assets | 2,765 | 2,753 | |||||
| Intangibles, net | 2,959 | 3,409 | |||||
| Goodwill | 2,677 | 2,677 | |||||
| Other assets | 2,957 | 2,580 | |||||
| TOTAL ASSETS | $ | 120,443 | $ | 42,736 | |||
| LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT | |||||||
| Current liabilities: | |||||||
| Account payable | $ | 1,722 | $ | 1,116 | |||
| Accrued expenses and other current liabilities | 10,573 | 7,249 | |||||
| Operating lease liabilities, current | 961 | 767 | |||||
| Deferred revenue, current | 28,403 | 17,894 | |||||
| Vendor financing arrangements, current | 833 | 643 | |||||
| Term loan | — | 557 | |||||
| Total current liabilities | 42,492 | 28,226 | |||||
| Deferred revenue, noncurrent | 20,773 | 15,014 | |||||
| Operating lease liabilities, noncurrent | 1,851 | 2,079 | |||||
| Vendor financing arrangements, noncurrent | 266 | 727 | |||||
| Other liabilities | 2,157 | 2,986 | |||||
| Total liabilities | 67,539 | 49,032 | |||||
| Redeemable convertible preferred stock: | |||||||
| Redeemable convertible preferred stock, par value of $0.001, no shares authorized, issued, and outstanding at December 31, 2021; 4,471,316 shares authorized, issued and outstanding at December 31, 2020 (aggregate liquidation preference of zero and $5,768 at December 31, 2021 and 2020, respectively) | — | 5,712 | |||||
| Stockholders' equity (deficit): | |||||||
| Preferred stock, par value of $0.001—10,000,000 and no shares authorized at December 31, 2021 and 2020, respectively; no shares issued and outstanding at December 31, 2021 and 2020 | — | — | |||||
| Common stock, par value of $0.001—300,000,000 and 31,525,154 shares authorized at December 31, 2021 and 2020, respectively; 31,530,682 and 18,486,989 shares issued and outstanding at December 31, 2021 and 2020, respectively | 31 | 18 | |||||
| Additional paid-in-capital | 91,945 | 3,612 | |||||
| Accumulated other comprehensive loss | (81 | ) | (31 | ) | |||
| Accumulated deficit | (38,991 | ) | (15,607 | ) | |||
| Total stockholders' equity (deficit) | 52,904 | (12,008 | ) | ||||
| TOTAL LIABILITIES REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) | $ | 120,443 | $ | 42,736 | |||
